Ibu and Vitiligo - a phase IV clinical study of FDA data

Summary:

Vitiligo is reported as a side effect among people who take Ibu (ibuprofen), especially for people who are male, 30-39 old, have been taking the drug for < 1 month also take Acetaminophen, and have High blood pressure.

The phase IV clinical study analyzes which people have Vitiligo when taking Ibu. It is created by eHealthMe based on reports of 240,078 people who have side effects when taking Ibu from the FDA, and is updated regularly.

What is Ibu?

Ibu has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 246,532 Ibu users. Check the latest studies of Ibu.

What is Vitiligo?

Vitiligo (pigment is lost from areas of the skin) is found to be associated with 168 drugs and 307 conditions by eHealthMe. Check the latest studies of Vitiligo.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

240,078 people reported to have side effects when taking Ibu.
Among them, 28 people (0.01%) have Vitiligo.

Among these 28 people:

How long have people been on Ibu when they have Vitiligo? *

What is the gender of people who have Vitiligo when taking Ibu? *

female: 20 %
male: 80 %

What is the age of people who have Vitiligo when taking Ibu? *

What are other drugs people take besides Ibu? *

Zopiclone: 4 people, 14.29%
Paracetamol: 4 people, 14.29%
Atenolol: 4 people, 14.29%
Clopidogrel: 4 people, 14.29%
Mebeverine Hydrochloride: 4 people, 14.29%
Acetaminophen: 4 people, 14.29%
Nasonex: 3 people, 10.71%
Remeron: 3 people, 10.71%
Ferrous Fumarate: 3 people, 10.71%
Vitamin B12: 3 people, 10.71%

What are other side effects people have besides Vitiligo? *

Thrombotic Thrombocytopenic Purpura (a rare blood disorder characterized by clotting in small blood vessels of the body): 7 people, 25.00%
Suicide Attempt: 7 people, 25.00%
Weakness: 6 people, 21.43%
Ocular Icterus (presence of jaundice seen in the sclera of the eye): 6 people, 21.43%
Conjunctivitis (pink eye): 5 people, 17.86%
Acute Myocardial Infarction (acute heart attack): 5 people, 17.86%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 5 people, 17.86%
Haematuria (presence of blood in urine): 4 people, 14.29%
Skin Hypopigmentation (loss of skin colour): 4 people, 14.29%
Joint Dislocation (a joint position is changed from normal position): 3 people, 10.71%

What are the existing conditions these people have? *

High Blood Pressure: 5 people, 17.86%
Nail Disorder (disease of nail): 4 people, 14.29%
Diarrhea: 4 people, 14.29%
Rashes (redness): 4 people, 14.29%
Joint Pain: 3 people, 10.71%
Oedema Peripheral (superficial swelling): 2 people, 7.14%
Malignant Melanoma (skin cancer rises from melancytes): 2 people, 7.14%
Malaise (a feeling of general discomfort or uneasiness): 2 people, 7.14%
Hepatitis C: 1 person, 3.57%
Anaemia (lack of blood): 1 person, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take Ibu and have Vitiligo?

- Check whether Vitiligo is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ibu:

Ibu (246,532 reports)

Vitiligo treatments and more:

Vitiligo (3,513 reports)

Browse all side effects of Ibu:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Vitiligo:

Vitiligo (168 drugs)

Browse all the conditions that are associated with Vitiligo:

Vitiligo (307 conditions)

Related publications that referenced our studies

Moslim MA, Sodeman TC, Nawras AT, "A Case of Suggested Ibuprofen-Induced Acute Pancreatitis", American journal of therapeutics, 2016 Nov .
Moslim MA, Sodeman TC, Nawras AT, "A Case of Suggested Ibuprofen-Induced Acute Pancreatitis", American journal of therapeutics, 2016 Nov .

How the study uses the data?

The study uses data from the FDA. It is based on ibuprofen (the active ingredients of Ibu) and Ibu (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.